Literature DB >> 15056453

Glutamate transporters: animal models to neurologic disease.

Nicholas J Maragakis1, Jeffrey D Rothstein.   

Abstract

Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056453     DOI: 10.1016/j.nbd.2003.12.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  112 in total

1.  Evidence that hyperprolinemia alters glutamatergic homeostasis in rat brain: neuroprotector effect of guanosine.

Authors:  Andréa G K Ferreira; Aline A da Cunha; Emilene B Scherer; Fernanda R Machado; Maira J da Cunha; Andressa Braga; Ben Hur Mussulini; Júlia D Moreira; Susana Wofchuk; Diogo O Souza; Angela T S Wyse
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

2.  Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes.

Authors:  Rujin Tian; Xiaoping Wu; Tracy L Hagemann; Alexandre A Sosunov; Albee Messing; Guy M McKhann; James E Goldman
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

Review 3.  Glial cells in neuronal network function.

Authors:  Alfonso Araque; Marta Navarrete
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-08-12       Impact factor: 6.237

Review 4.  Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia.

Authors:  Korapat Mayurasakorn; Jill J Williams; Vadim S Ten; Richard J Deckelbaum
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

5.  Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.

Authors:  Geraldine T Petr; Yan Sun; Natalie M Frederick; Yun Zhou; Sameer C Dhamne; Mustafa Q Hameed; Clive Miranda; Edward A Bedoya; Kathryn D Fischer; Wencke Armsen; Jianlin Wang; Niels C Danbolt; Alexander Rotenberg; Chiye J Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

6.  In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine.

Authors:  Rejane G Tavares; André P Schmidt; Jamile Abud; Carla I Tasca; Diogo O Souza
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

7.  Can zebrafish be used as animal model to study Alzheimer's disease?

Authors:  Soraya Santana; Eduardo P Rico; Javier S Burgos
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

Review 8.  PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.

Authors:  Mario Vallejo
Journal:  Mol Neurobiol       Date:  2009-02-24       Impact factor: 5.590

9.  Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.

Authors:  Ke Li; Elham Javed; Tamara J Hala; Daniel Sannie; Kathleen A Regan; Nicholas J Maragakis; Megan C Wright; David J Poulsen; Angelo C Lepore
Journal:  Mol Ther       Date:  2014-12-10       Impact factor: 11.454

10.  Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose.

Authors:  Graeme F Mason; Kitt Falk Petersen; Robin A de Graaf; Gerald I Shulman; Douglas L Rothman
Journal:  J Neurochem       Date:  2006-10-31       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.